Van den Mooter G - Search Results

1

Pharmaceutical Applications of Electrospraying.

Nguyen DN, Clasen C, Van den Mooter G. Nguyen DN, et al. Among authors: van den mooter g. J Pharm Sci. 2016 Sep;105(9):2601-2620. doi: 10.1016/j.xphs.2016.04.024. Epub 2016 Jun 7. J Pharm Sci. 2016. PMID: 27287515 Review.

2

Characterization of methacrylated inulin hydrogels designed for colon targeting: in vitro release of BSA.

Van den Mooter G, Vervoort L, Kinget R. Van den Mooter G, et al. Pharm Res. 2003 Feb;20(2):303-7. doi: 10.1023/a:1022295725841. Pharm Res. 2003. PMID: 12636172

3

Increased physical stability and improved dissolution properties of itraconazole, a class II drug, by solid dispersions that combine fast- and slow-dissolving polymers.

Six K, Verreck G, Peeters J, Brewster M, Van Den Mooter G. Six K, et al. Among authors: van den mooter g. J Pharm Sci. 2004 Jan;93(1):124-31. doi: 10.1002/jps.10522. J Pharm Sci. 2004. PMID: 14648642

4

Characterization of ternary solid dispersions of itraconazole, PEG 6000, and HPMC 2910 E5.

Janssens S, de Armas HN, Roberts CJ, Van den Mooter G. Janssens S, et al. Among authors: van den mooter g. J Pharm Sci. 2008 Jun;97(6):2110-20. doi: 10.1002/jps.21128. J Pharm Sci. 2008. PMID: 17847067

5

Pharmaceutical aspects of drug eluting stents.

Deconinck E, Sohier J, De Scheerder I, Van den Mooter G. Deconinck E, et al. Among authors: van den mooter g. J Pharm Sci. 2008 Dec;97(12):5047-60. doi: 10.1002/jps.21356. J Pharm Sci. 2008. PMID: 18384155 Review.

6

Drying of crystalline drug nanosuspensions-the importance of surface hydrophobicity on dissolution behavior upon redispersion.

Van Eerdenbrugh B, Froyen L, Van Humbeeck J, Martens JA, Augustijns P, Van den Mooter G. Van Eerdenbrugh B, et al. Among authors: van humbeeck j, van den mooter g. Eur J Pharm Sci. 2008 Sep 2;35(1-2):127-35. doi: 10.1016/j.ejps.2008.06.009. Epub 2008 Jul 3. Eur J Pharm Sci. 2008. PMID: 18644441

7

A screening study of surface stabilization during the production of drug nanocrystals.

Van Eerdenbrugh B, Vermant J, Martens JA, Froyen L, Van Humbeeck J, Augustijns P, Van den Mooter G. Van Eerdenbrugh B, et al. Among authors: van humbeeck j, van den mooter g. J Pharm Sci. 2009 Jun;98(6):2091-103. doi: 10.1002/jps.21563. J Pharm Sci. 2009. PMID: 18803265

8

Ordered mesoporous silica material SBA-15: a broad-spectrum formulation platform for poorly soluble drugs.

Van Speybroeck M, Barillaro V, Thi TD, Mellaerts R, Martens J, Van Humbeeck J, Vermant J, Annaert P, Van den Mooter G, Augustijns P. Van Speybroeck M, et al. Among authors: van humbeeck j, van den mooter g. J Pharm Sci. 2009 Aug;98(8):2648-58. doi: 10.1002/jps.21638. J Pharm Sci. 2009. PMID: 19072861

9

Formulate-ability of ten compounds with different physicochemical profiles in SMEDDS.

Thi TD, Van Speybroeck M, Barillaro V, Martens J, Annaert P, Augustijns P, Van Humbeeck J, Vermant J, Van den Mooter G. Thi TD, et al. Among authors: van speybroeck m, van humbeeck j, van den mooter g. Eur J Pharm Sci. 2009 Dec 8;38(5):479-88. doi: 10.1016/j.ejps.2009.09.012. Epub 2009 Sep 24. Eur J Pharm Sci. 2009. PMID: 19782131

10

Structural transformations during swelling of polycomplex matrices based on countercharged (meth)acrylate copolymers (Eudragit EPO/Eudragit L 100-55).

Moustafine RI, Bobyleva VL, Bukhovets AV, Garipova VR, Kabanova TV, Kemenova VA, Van Den Mooter G. Moustafine RI, et al. Among authors: van den mooter g. J Pharm Sci. 2011 Mar;100(3):874-85. doi: 10.1002/jps.22320. Epub 2010 Aug 27. J Pharm Sci. 2011. PMID: 20803617

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

250 results

Search Page